DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Zibotentan is an investigational drug.
There have been 20 clinical trials for Zibotentan. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2008.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Neoplasms, and Neoplasm Metastasis. The leading clinical trial sponsors are AstraZeneca, Cardiff University, and NHS Greater Glasgow and Clyde.
Recent Clinical Trials for Zibotentan
|Study of ET-1 SNP Effects on ET-1 Antagonism in Coronary Microvascular Disease||Papworth Hospital NHS Foundation Trust||Phase 2|
|Precision Medicine With Zibotentan in Microvascular Angina||University of Glasgow||Phase 2|
|Precision Medicine With Zibotentan in Microvascular Angina||NHS Greater Glasgow and Clyde||Phase 2|